AI Model for Early Detection of SARS-CoV2 in Children Could Pave Way for Rapid Bedside COVID-19 Diagnostic Device
An artificial intelligence (AI) model to aid in the early detection of severe SARS-CoV2 illness in children is expected to improve outcomes via early recognition, timely intervention and appropriate allocation of critical resources, as well as lead to the development of a rapid bedside COVID-19 diagnostic device. More...05 Feb 2021
Becton Dickinson Launches Assay for Determining COVID-19 Patients’ Risk of IMV and Mortality at Hospitalization
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has announced the CE mark of BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes with expanded clinical application to help clinicians identify COVID-19 patients at increased relative risk of intubation with mechanical ventilation (IMV) and mortality at hospital admission, in conjunction with clinical findings and the results of other laboratory testing. More...05 Feb 2021
10-Minute COVID-19 Diagnostic Test Based on Nanoparticles Identifies IgG Antibodies and Costs Only Fifth of Market Average
A new COVID-19 test uses technology based on nanoparticles to detect antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average. More...04 Feb 2021
Deep-Learning Model that Can Predict How Human Genes and Medicines Will Interact Identifies Promising COVID-19 Treatments
A new deep-learning model that can predict how human genes and medicines will interact has identified at least 10 compounds that may hold promise as treatments for COVID-19. More...03 Feb 2021
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Transducer Covers
Surgi Intraoperative Covers
New
Mobile Barrier
Tilted Mobile Leaded Barrier
In Other News
ECMO Life-Support Therapy Can Improve Survival of COVID-19 Patients with Severe Respiratory Failure, Suggests Study
New Simple, 15-Minute Sample-to-Answer COVID-19 Test Used with Desktop Detection System Costs Less than USD 2
Hand-Held Biosensor Device Could Enable Immediate, Sensitive Point-of-Care Detection of SARS-CoV-2 from Saliva
Seegene Develops World’s First COVID-19 Mutant Identification Test
New Imaging-Based Serology Test Platform for COVID-19 to Confirm Activity of SARS-CoV-2 Vaccines
SARS-CoV-2 Gene Database Offers Precision Medicine Approach for Tailoring COVID-19 Treatments
Protein-Based Biosensors That Glow When Mixed With SARS-CoV-2 Components or Antibodies Could Enable Faster COVID-19 Testing
New COVID-19 Test Uses Smartphone Microscope to Analyze Saliva Samples and Deliver Results in 10 Minutes
New Yeast-Based COVID-19 Diagnostic Test Could Detect SARS-CoV-2 in Saliva Faster Than RT-PCR
Novavax COVID-19 Vaccine Becomes First to Demonstrate Clinical Efficacy against COVID-19 and Both UK and South Africa Variants
Johnson & Johnson Single-Shot Janssen COVID-19 Vaccine Candidate 66% Effective in Phase 3 Study
YHLO Offers Series of SARS-CoV-2 Antigen Test Products to Meet Demand for Global COVID-19 Mass Screening
Commonly Used Antibiotics Azithromycin and Doxycycline Not Generally Effective Treatments for COVID-19, Finds Trial
First, Large High-Quality Trial for ‘Wonder Drug’ Ivermectin Could Dramatically Reduce COVID-19 Deaths
New Understanding of How Gilead’s Remdesivir Inhibits SARS-CoV-2 Could Help Develop COVID-19 Antivirals
AI-Based Multi-Modal COVID-19 Risk Score Improves Severity Prediction of Hospitalized COVID-19 Patients
Mathematical Model Could Help Clinicians to Safely Allow Two COVID-19 Patients to Share Single Ventilator
Ultra-Absorptive Nanofiber Swabs Could Improve SARS-CoV-2 Test Sensitivity
SARS-CoV-2 Antibodies Cross-React with Other Coronavirus Strains, Raising Important Implications for COVID-19 Diagnosis
Novel SARS CoV-2 Saliva Collection Devices Improve Lab Efficiency and PCR Test Performance
Abbott's Panbio COVID-19 Ag Rapid Test Receives CE Mark for Asymptomatic Testing and Self-Swabbing
Eli Lilly's Twin Neutralizing Antibody Combo Treatment Reduces Risk of COVID-19 Hospitalizations and Death by 70%
Regeneron’s Antibody Cocktail Works as Passive COVID-19 Vaccine, Shows New Study
